-transparent.png){kind=logo}
In the anaesthetized dog, porcine pancreastatin (98 pmol/min) was infused for 10 min into the pancreaticoduodenal artery either alone or during infusion of glucose. Blood was sampled from the pancreaticoduodenal vein. We found that pancreastatin inhibited pancreatic insulin output only under normoglycaemic conditions. Furthermore, pancreastatin significantly stimulated pancreatic glucagon and somatostatin outputs both during normo- and hyperglycaemic conditions. Our results show that pancreastatin has the capability to affect directly the three pancreatic hormone secretions in dogs.
Related Publications
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
October 1989,
Endocrinologia japonica,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
March 1985,
Archives internationales de pharmacodynamie et de therapie,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
January 1976,
Clinical and experimental pharmacology & physiology,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
January 1989,
Pancreas,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
February 1988,
Acta physiologica Scandinavica,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
June 1990,
Diabetes research (Edinburgh, Scotland),
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
January 1982,
Clinical and experimental pharmacology & physiology,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
April 1986,
Archives internationales de pharmacodynamie et de therapie,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
May 1989,
Regulatory peptides,
G Ribes, and
F Vecina, and
D Hillaire-Buys, and
B Ahren
January 1989,
Digestion,
